Screening patients with chronic hepatitis B infection (HBsAg+) for hepatocellular carcinoma by alpha-fetoprotein (AFP) or by AFP plus ultrasound (AFP/US) detects hepatocellular carcinoma tumors at earlier stages and increases resection rates (strength of recommendation [SOR]: B, based on a systematic review of fair-quality randomized controlled trials). It is unclear whether screening with AFP or AFP/US improves disease-specific or all-cause mortality (SOR: B).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hepatocellular carcinoma
12
best surveillance
4
surveillance hepatocellular
4
carcinoma chronic
4
chronic carriers
4
carriers hepatitis
4
hepatitis screening
4
screening patients
4
patients chronic
4
chronic hepatitis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!